As part of our virtual 'Special Guest Seminars' series, the UK DRI is delighted to welcome Prof Ray Dolan.
'An early marker for Alzheimer’s Disease?'
Memory and decision making impairment are fundamental deficits in neurodegenerative diseases, including Alzheimer’s Disease. An important therapeutic goal has been to identify physiological markers that might serve as early, and sensitive, targets for interventions. I will present new work from my lab which bears on this question. This will include novel findings that identify physiological signatures predicting the efficacy of memory and inferential decision making. I will also show in a disease model that these signatures breakdown are predictive of the efficacy of learning.
Tuesday 6 October, 12:00 - 13:00 BST
This event is open to UK DRI researchers and support staff only. Registration and associated Zoom links will be distributed via Centre Manager emails nearer the time of the event.
Prof Ray Dolan
Mary Kinross Professor of Neuropsychiatry
Director of the Max Planck Centre for Computational Psychiatry and Ageing, UCL
Ray Dolan is a Mary Kinross Professor of Neuropsychiatry and Director of the Max Planck Centre for Computational Psychiatry and Ageing, at UCL. He was founding Director of the Wellcome Trust Centre for Human Neuroimaging (2006). His primary research interests include reward, learning and decision making. He holds an honorary Professorship at the Humboldt University Berlin and is an External Member of the Max Planck Society. He is a Member of the Royal Irish Academy (MRIA) and a Fellow of the Royal Society (FRS). He is the recipient of numerous international awards including the Minerva Foundation Golden Brain Award, (2006), the Max Planck International Research Award (2007), the Klaus Joachim Zülch Prize (2013) and the Brain Prize (2017). He has recently been awarded the Royal Society 2019 Ferrier Medal and Lecture.
